item 2.02

Results of Operations and Financial Condition

The earnings-release item. Filed when the company publicly announces results — typically a press release attached as Exhibit 99.1. Information is 'furnished, not filed,' which has a narrower liability profile under the Exchange Act.

showing 50 recent 8-Ks latest May 13, 2026 15:46 UTC

Recent disclosures

May 13, 2026 15:46 UTC KFFB Kentucky First Federal Bancorp earnings

Kentucky First Federal Bancorp Q3 net income $581K; nine-month net $1.2M, both up sharply
May 13, 2026 13:18 UTC NEON Neonode Inc. earnings

Neonode Q1 2026 revenue $0.6M (+19.7% YoY), loss from operations $1.9M
May 13, 2026 13:05 UTC CIMG CIMG Inc. earnings

CIMG Q2 revenue $3.2M; 6-month revenue $18.9M (82,969% YoY); holds 730 BTC worth $49.85M
May 13, 2026 13:00 UTC BBGI BEASLEY BROADCAST GROUP INC earnings

Beasley Q1 rev $42.6M (-12.9% YoY); net income $3.2M ($1.77/dil EPS) vs prior yr loss
May 13, 2026 12:35 UTC LITS Lite Strategy, Inc. other_material

Lite Strategy reports $0.7M yield from LTC covered calls, repurchases 1.6M shares
May 13, 2026 12:32 UTC FATE FATE THERAPEUTICS INC earnings

Fate Therapeutics Q1 2026: $174.8M cash, $1.3M revenue; FT819 lupus trial on track
May 13, 2026 12:30 UTC SSII SS Innovations International, Inc. earnings

SS Innovations Q1 revenue $11.1M (+117% YoY); net loss narrows to $3.6M; installations up 73%
May 13, 2026 12:15 UTC QTIWW QT IMAGING HOLDINGS, INC. earnings

QT Imaging Q1 revenue $6.5M (+133% YoY); net loss $3.4M; reaffirms FY2026 guidance ~$39M
May 13, 2026 12:14 UTC ASTC ASTROTECH Corp earnings

Astrotech Q3 FY2026: R&D expense down 28%; TRACER 1000 deployed in 37 sites across 16 countries
May 13, 2026 12:09 UTC IPSC Century Therapeutics, Inc. earnings

Century Therapeutics reports Q1 net loss of $21.6M; cash runway into Q1 2029; CNTY-813 IND on track for 4Q 2026
May 13, 2026 12:05 UTC TULP BLOOMIA HOLDINGS, INC. earnings

Bloomia Q3 revenue up 16% to $14.4M but swings to $0.8M net loss; completes $12.1M rights offering
May 13, 2026 12:05 UTC SPRB SPRUCE BIOSCIENCES, INC. earnings

Spruce Biosciences Q1 net loss $12.3M; cash $54.1M (Mar 31), $107.3M (Apr 30)
May 13, 2026 12:05 UTC XBIO Xenetic Biosciences, Inc. earnings

Xenetic Biosciences Q1 2026 net loss down 49% to $0.5M; royalty revenue up 36% to $0.8M
May 13, 2026 12:05 UTC TARA Protara Therapeutics, Inc. earnings

Protara Therapeutics Reports Q1 2026 Results, Advances TARA-002 Programs in LMs and NMIBC
May 13, 2026 12:00 UTC TYRA Tyra Biosciences, Inc. earnings

Tyra Biosciences Q1 net loss $39.3M; cash $383.5M; SURF302 data August 2026
May 13, 2026 11:43 UTC LOCLW Local Bounti Corporation/DE earnings

Local Bounti Q1 2026 revenue $13.3M (+15% YoY), net loss improves to $12.7M from $37.7M
May 13, 2026 11:34 UTC ALT Altimmune, Inc. earnings

Altimmune Q1 net loss $22.6M; cash $535M; PERFORMA Phase 3 MASH trial initiation in H2 2026
May 13, 2026 11:31 UTC ABUS Arbutus Biopharma Corp earnings

Arbutus Q1 net income $169.7M ($0.88/share) on $179.1M revenue from Moderna settlement
May 13, 2026 11:31 UTC VSH VISHAY INTERTECHNOLOGY INC earnings

Vishay Q1 revenues $839.2M, GAAP EPS $0.05; book-to-bill 1.34
May 13, 2026 11:30 UTC ABEO ABEONA THERAPEUTICS INC. earnings

Abeona Q1 net product revenue $8.7M; three ZEVASKYN patients treated; in-licenses PSMA T-cell therapy
May 13, 2026 11:23 UTC MIST Milestone Pharmaceuticals Inc. earnings

Milestone Q1 2026 net loss $26.1M; CARDAMYST launch yields $0.2M revenue, 600 scripts
May 13, 2026 11:07 UTC CWBHF Charlotte's Web Holdings, Inc. earnings

Charlotte's Web Q1 2026 revenue down 9% to $11.2M, net loss $13.1M, proposes BAT transaction to eliminate debenture
May 13, 2026 11:05 UTC XTNT Xtant Medical Holdings, Inc. earnings

Xtant Medical Q1 2026 net loss $3.1M; revenue falls to $20.9M, raises 2026 guidance to $101-105M
May 13, 2026 11:05 UTC PDSB PDS Biotechnology Corp earnings

PDS Biotech Q1 net loss $7.3M ($0.13/sh); VERSATILE-003 amended with PFS endpoint
May 13, 2026 11:05 UTC UPB Upstream Bio, Inc. earnings

Upstream Bio reports Q1 net loss $40.6M; Phase 3 plans on track for 2027
May 13, 2026 11:04 UTC ANRO Alto Neuroscience, Inc. earnings

Alto Neuroscience Q1 net loss $26.2M; initiates Phase 2b trial for ALTO-207 in TRD
May 13, 2026 11:01 UTC IMUX IMMUNIC, INC. earnings

Immunic reports Q1 net loss $32.6M; cash $186.6M; Phase 3 MS data by end-2026
May 13, 2026 11:00 UTC AVTX Avalo Therapeutics, Inc. earnings

Avalo reports Q1 net loss $19.6M, Phase 2 HS trial meets endpoints, $431M offering
May 13, 2026 11:00 UTC BYSI BeyondSpring Inc. earnings

BeyondSpring Q1 net loss $2.4M from continuing ops; cash $7.9M; AACR data supports Plinabulin-ADC combo
May 13, 2026 11:00 UTC VERU VERU INC. earnings

Veru Q2 net loss $2.7M; PLATEAU trial interim analysis expected Q1 2027
May 13, 2026 10:57 UTC PLX Protalix BioTherapeutics, Inc. earnings

Protalix BioTherapeutics Reports First Quarter 2026 Financial Results and Reaffirms Guidance
May 13, 2026 10:36 UTC EOSE Eos Energy Enterprises, Inc. m_and_a

Eos forms $250M JV with Cerberus for LDES IPP; Q1 rev $57M, guides FY $300-400M
May 13, 2026 10:35 UTC APRE Aprea Therapeutics, Inc. earnings

Aprea Q1 net loss $3.3M ($0.22/sh); cash $46.5M; APR-1051 shows two partial responses
May 13, 2026 10:33 UTC DT Dynatrace, Inc. earnings

Dynatrace Q4 ARR surpasses $2B (+18% YoY); non-GAAP EPS $0.41 on revenue $532M
May 13, 2026 10:31 UTC CTM Castellum, Inc. earnings

Castellum Q1 revenue up 23% to $14.3M; record backlog $273M; net loss improves to $0.4M
May 13, 2026 10:30 UTC CMPS COMPASS Pathways plc earnings

Q1 net income $91.2M on warrant gain; cash $466M; FDA grants COMP360 rolling NDA submission
May 13, 2026 10:14 UTC ZBIO Zenas BioPharma, Inc. earnings

Zenas BioPharma Q1 net loss $81M; obexelimab BLA on track
May 13, 2026 10:06 UTC EYE National Vision Holdings, Inc. earnings

National Vision Q1 revenue $543.9M (+6.6%), EPS $0.38, adj. EPS $0.45; margin expands 210bps
May 13, 2026 10:02 UTC RGS REGIS CORP earnings

Regis Q3 FY2026 net income $0.7M ($0.26 EPS); adjusted EPS $0.57, consolidated SSS +2.6%
May 13, 2026 00:39 UTC AVR Anteris Technologies Global Corp. earnings

Anteris raises $320M, Q1 cash burn $28.7M; PARADIGM trial enrols in US
May 13, 2026 00:09 UTC AZTR Azitra, Inc. earnings

Azitra Q1 net loss $3.9M; adds MD Anderson for ATR-04 trial
May 12, 2026 21:20 UTC IAUX-WT i-80 Gold Corp. earnings

i-80 Gold reports Q1 2026 revenue $52.4M, gross profit $16.1M; fully funded development plan on track
May 12, 2026 21:16 UTC GRUSF Grown Rogue International Inc. earnings

Grown Rogue Q1 2026 revenue up 28% to $9.2M, net loss $2.2M; raises 2026 revenue guidance to $34-37M
May 12, 2026 21:15 UTC TGEN TECOGEN INC. earnings

Q1 revenue $6.34M, net loss $2.12M; Vertiv 1 MW chiller order imminent
May 12, 2026 21:12 UTC FONR FONAR CORP earnings

FONAR Q3 net income down 25% to $2.3M; shareholder vote on take-private set for May 28
May 12, 2026 21:08 UTC EPM EVOLUTION PETROLEUM CORP earnings

Evolution Petroleum Q3 net loss $8.9M; revenue down 11% YoY; EBITDA falls 58%
May 12, 2026 21:07 UTC BBOT BridgeBio Oncology Therapeutics, Inc. earnings

BBOT Q1 net loss widens to $42.1M; cash $388.9M funds ops into 2028; pipeline shows early efficacy
May 12, 2026 21:06 UTC ROLR High Roller Technologies, Inc. earnings

High Roller Q1 net revenue down 35% to $3.4M; launches ROLR prediction markets with CDNA
May 12, 2026 21:00 UTC DIOD DIODES INC /DEL/ earnings

Diodes reports Q1 2026 earnings; no specific numbers in 8-K exhibit
May 12, 2026 21:00 UTC RLMD RELMADA THERAPEUTICS, INC. other_material

Relmada reports Q1 2026 net loss of $19.1M; NDV-01 Phase 2 shows 95% CR rate; cash $234M through 2029

source · SEC Form 8-K instructions · see methodology